MeiraGTx Holdings (MGTX) Receivables Refunds (2018 - 2025)
MeiraGTx Holdings posted quarterly Receivables Refunds of $15.3 million for Q4 2025, up 70.39% year-on-year from $9.0 million in Q4 2024, and up 69.81% on a QoQ basis from $9.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 8 years of Receivables Refunds data on file, last reported at $15.3 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables Refunds rose 70.39% year-over-year to $15.3 million; the trailing twelve-month figure through Dec 2025 stood at $15.3 million (up 70.39% YoY), and the FY2025 full-year result was $15.3 million, up 70.39% from the prior year.
- Receivables Refunds for Q4 2025 stood at $15.3 million, up from $9.0 million in the prior quarter.
- Across five years, Receivables Refunds topped out at $15.3 million in Q4 2025 and bottomed at $3.6 million in Q2 2024.
- The 5-year median for Receivables Refunds is $7.6 million (2021), against an average of $8.1 million.
- The widest annual swing landed in 2023, when Receivables Refunds jumped 104.47%; it then slumped 67.95% in 2025.
- A 5-year view of Receivables Refunds shows it stood at $12.6 million in 2021, then plunged by 39.14% to $7.7 million in 2022, then jumped by 72.68% to $13.3 million in 2023, then plunged by 32.43% to $9.0 million in 2024, then surged by 70.39% to $15.3 million in 2025.
- The last three Receivables Refunds figures came in at $15.3 million (Q4 2025), $9.0 million (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 15.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.29 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 4.47 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 13.17 Mn |
| Dec 31, 2023 | 13.28 Mn |
| Sep 30, 2023 | 10.01 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 7.86 Mn |
| Dec 31, 2022 | 7.69 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Mar 31, 2022 | 6.87 Mn |
| Dec 31, 2021 | 12.63 Mn |
| Sep 30, 2021 | 5.38 Mn |
| Jun 30, 2021 | 7.43 Mn |
| Mar 31, 2021 | 7.39 Mn |
| Dec 31, 2020 | 12.93 Mn |
| Sep 30, 2020 | 7.09 Mn |
| Jun 30, 2020 | 6.78 Mn |
| Mar 31, 2020 | 6.82 Mn |
| Dec 31, 2019 | 11.97 Mn |
| Dec 31, 2018 | 3.42 Mn |